EWING, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. XYOSTED™ is the only FDA approved ...
If you have low testosterone levels, your doctor may recommend testosterone replacement therapy with Xyosted. Xyosted is a prescription drug used in adult males* to treat testosterone deficiency (low ...
Xyosted (testosterone enanthate) is a prescription drug used to treat low testosterone levels in certain people. The drug comes as a liquid solution inside prefilled autoinjector pens. It’s usually ...
Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events. The Food and Drug Administration (FDA) has approved ...
EWING, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS), a pharmaceutical technology company, today announced they have entered into an exclusive distribution agreement with ...
Prior to starting Xyosted, the patient's baseline cardiovascular risk should be considered and blood pressure should be adequately controlled. Antares Pharma announced the launch of Xyosted ...
The US Food and Drug Administration (FDA) has declined to approve a new drug application (NDA) for testosterone enanthate (Xyosted, Antares Pharma) in a proprietary autoinjector and has raised two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback